BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses

Read more ➡
Science in Seattle Logo

Science in Seattle: Targeting the Genetic Roots of Autoimmunity

News icon

Early introduction of gluten may prevent celiac disease in children

Read More

Thu “Kim” Le interns with Benaroya Research Institute, doing cancer research from home

Read more ➡
News Main Image - Healthline

‘Lost time and momentum’

News icon

Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses

Read More
Test

Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases

Read More
News icon

GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases

Read More

New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI

Read more ➡
News icon

GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology

Read More
News icon

Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason

Read More
News icon

Lynn Rose, PhD, to Retire from Benaroya Research Institute at Virginia Mason

Read More

Benaroya Research Institute awarded $5.8M from NIH for immunology-related COVID research

Read more ➡
News icon

Dr. Harrison Awarded First NOSTER Science Microbiome Prize

Read More

Benaroya Research Institute at Virginia Mason is a leader in finding cure to autoimmune diseases

Watch video ➡